Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myelom

Links shared publicly online about this topic.

  • 925
    total visits

Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myelom

thelancet.com —

Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and pre...

View full resource at thelancet.com

Tags: Leprosy Medication, Multiple Myeloma, Senior Health, Thalomid, Prednisone, Thalidomide

  • Share

Most Recently Shared on August 24, 2010 at 1:03 pm By:

ThomasReid3MD Thomas J Reid MD PhD

Multiple Myeloma: Reduced-intensity bortezomib-based regimen is safe and effective therapy for elderly patients. http://bit.ly/anPFjo

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

The Lancet The Lancet

Advertisement